THERESA ROURKE: Open Payments
NPI 1912309162 · LANGHORNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$948 in 22 payments from 11 companies in 2025. Trend: 2023 $1,570 · 2024 $1,211 · 2025 $948
Food & beverage: $948
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $304 |
| Alnylam Pharmaceuticals Inc. | 2 | $147 |
| Novo Nordisk Inc | 2 | $132 |
| Merck Sharp & Dohme LLC | 6 | $119 |
| Gilead Sciences, Inc. | 1 | $117 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| PFIZER INC. | 1 | $23 |
| BridgeBio Pharma, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Wegovy, AIRSUPRA, AMVUTTRA, BREZTRI, VERQUVO, Descovy, WAINUA, LEQVIO.
Industry payments across PA — which companies pay providers there.
